Ligand validation:6Q5B

NXL: (2S,5R)-1-formyl-5-[(sulfooxy)amino]piperidine-2-carboxamide

NXL is a Ligand Of Interest in 6Q5B designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6Q5B_NXL_A_301	78%	12%	0.118	0.961	1.92	2.12	3	5	1	0	100%	1
6Q5B_NXL_C_301	78%	7%	0.12	0.963	2.45	2.31	3	7	0	0	100%	1
6Q5B_NXL_D_301	61%	6%	0.153	0.943	2.39	2.62	4	10	0	0	100%	1
6Q5B_NXL_B_301	57%	13%	0.151	0.926	2.18	1.75	2	5	0	0	100%	1
4S2K_NXL_C_301	94%	16%	0.075	0.974	1.13	2.54	1	7	1	0	100%	1
4S2N_NXL_C_301	90%	9%	0.081	0.964	1.24	3.14	1	8	0	0	100%	1
4WMC_NXL_B_301	89%	37%	0.1	0.979	0.83	1.61	-	4	0	0	100%	1
7O5N_NXL_DDD_302	83%	44%	0.096	0.954	0.6	1.55	-	2	0	0	100%	0.8471
4S2J_NXL_C_301	71%	9%	0.154	0.976	1.17	3.19	2	8	0	0	100%	1
4HBU_NXL_A_301	100%	51%	0.04	0.993	0.56	1.31	-	1	0	0	100%	1
9BZQ_NXL_A_401	99%	38%	0.059	0.986	1.51	0.93	1	-	0	0	100%	1
4S2I_NXL_B_301	95%	12%	0.067	0.971	2.1	1.99	4	6	0	0	100%	1
8EK9_NXL_A_301	94%	10%	0.067	0.968	1.93	2.38	4	5	0	0	100%	1
5MOZ_NXL_A_701	94%	19%	0.067	0.967	1.87	1.56	4	5	0	0	100%	0.9412

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.